Singapore markets close in 2 hours 51 minutes
Straits Times Index
3,293.35 +0.66 (+0.02%) Nikkei
38,234.84 -39.21 (-0.10%) Hang Seng
18,210.22 +447.19 (+2.52%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,512.49 -2,341.83 (-3.91%) CMC Crypto 200
1,259.09 -11.65 (-0.92%)
MorphoSys AG (0NDV.IL)
IOB - IOB Delayed price. Currency in EUR
Add to watchlist
At close: 05:13PM BST
| Previous close | 66.50 |
| Open | 0.00 |
| Bid | 64.85 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 175,974 |
| Market cap | 2.301B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 26.49 |
| EPS (TTM) | 2.51 |
| Earnings date | 29 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireMorphoSys AG Reports First Quarter 2024 Financial Results
PLANEGG/MUNICH, Germany, April 29, 2024--MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2024.
ZacksNovartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.
- Zacks
Novartis (NVS) to Undertake Job Cuts in Development Department
Novartis (NVS) is set to cut jobs by 680 in its development organization to reshape workforce.
© 2024 Yahoo. All rights reserved.